453 related articles for article (PubMed ID: 10884437)
1. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.
Wulff H; Miller MJ; Hansel W; Grissmer S; Cahalan MD; Chandy KG
Proc Natl Acad Sci U S A; 2000 Jul; 97(14):8151-6. PubMed ID: 10884437
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.
Ghanshani S; Wulff H; Miller MJ; Rohm H; Neben A; Gutman GA; Cahalan MD; Chandy KG
J Biol Chem; 2000 Nov; 275(47):37137-49. PubMed ID: 10961988
[TBL] [Abstract][Full Text] [Related]
3. Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1.
Wulff H; Gutman GA; Cahalan MD; Chandy KG
J Biol Chem; 2001 Aug; 276(34):32040-5. PubMed ID: 11425865
[TBL] [Abstract][Full Text] [Related]
4. Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo.
Grgic I; Eichler I; Heinau P; Si H; Brakemeier S; Hoyer J; Köhler R
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):704-9. PubMed ID: 15662023
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
6. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.
Mark Duffy S; Berger P; Cruse G; Yang W; Bolton SJ; Bradding P
J Allergy Clin Immunol; 2004 Jul; 114(1):66-72. PubMed ID: 15241346
[TBL] [Abstract][Full Text] [Related]
7. The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.
Jensen BS; Hertz M; Christophersen P; Madsen LS
Expert Opin Ther Targets; 2002 Dec; 6(6):623-36. PubMed ID: 12472376
[TBL] [Abstract][Full Text] [Related]
8. The Ca2+-activated K+ channel of intermediate conductance: a molecular target for novel treatments?
Jensen BS; Strøbaek D; Olesen SP; Christophersen P
Curr Drug Targets; 2001 Dec; 2(4):401-22. PubMed ID: 11732639
[TBL] [Abstract][Full Text] [Related]
9. Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer.
Wang ZH; Shen B; Yao HL; Jia YC; Ren J; Feng YJ; Wang YZ
Oncogene; 2007 Aug; 26(35):5107-14. PubMed ID: 17310992
[TBL] [Abstract][Full Text] [Related]
10. Facilitation of Ca2+-activated K+ channels (IKCa1) by mibefradil in B lymphocytes.
Yoo HY; Zheng H; Nam JH; Nguyen YH; Kang TM; Earm YE; Kim SJ
Pflugers Arch; 2008 Jun; 456(3):549-60. PubMed ID: 18188587
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of blockage of intermediate conductance Ca(2+)-activated K (+) channels on proliferation of hepatocellular carcinoma cells.
Yang XW; Liu JW; Zhang RC; Yin Q; Shen WZ; Yi JL
J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):86-89. PubMed ID: 23392713
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis.
Köhler R; Wulff H; Eichler I; Kneifel M; Neumann D; Knorr A; Grgic I; Kämpfe D; Si H; Wibawa J; Real R; Borner K; Brakemeier S; Orzechowski HD; Reusch HP; Paul M; Chandy KG; Hoyer J
Circulation; 2003 Sep; 108(9):1119-25. PubMed ID: 12939222
[TBL] [Abstract][Full Text] [Related]
13. TRAM-34, a putatively selective blocker of intermediate-conductance, calcium-activated potassium channels, inhibits cytochrome P450 activity.
Agarwal JJ; Zhu Y; Zhang QY; Mongin AA; Hough LB
PLoS One; 2013; 8(5):e63028. PubMed ID: 23667566
[TBL] [Abstract][Full Text] [Related]
14. Structure-guided transformation of charybdotoxin yields an analog that selectively targets Ca(2+)-activated over voltage-gated K(+) channels.
Rauer H; Lanigan MD; Pennington MW; Aiyar J; Ghanshani S; Cahalan MD; Norton RS; Chandy KG
J Biol Chem; 2000 Jan; 275(2):1201-8. PubMed ID: 10625664
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels.
Jensen BS; Odum N; Jorgensen NK; Christophersen P; Olesen SP
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10917-21. PubMed ID: 10485926
[TBL] [Abstract][Full Text] [Related]
16. K+ channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression.
Panyi G; Possani LD; Rodríguez de la Vega RC; Gáspár R; Varga Z
Curr Pharm Des; 2006; 12(18):2199-220. PubMed ID: 16787250
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-Conductance-Ca2-Activated K Channel IKCa1 Is Upregulated and Promotes Cell Proliferation in Cervical Cancer.
Liu L; Zhan P; Nie D; Fan L; Lin H; Gao L; Mao X
Med Sci Monit Basic Res; 2017 Mar; 23():45-57. PubMed ID: 28280257
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.
Tharp DL; Wamhoff BR; Turk JR; Bowles DK
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2493-503. PubMed ID: 16798818
[TBL] [Abstract][Full Text] [Related]
19. [Effects of telmisartan on IKCa1 potassium channel after T-lymphocyte activation and proliferation in peripheral blood of hypertensive patients in Xinjiang Kazakh].
Zhang Q; Zhang Y; Cheng L; Yuan Q; Zhang G; Gou F
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(3):182-6. PubMed ID: 24731458
[TBL] [Abstract][Full Text] [Related]
20. [Intermediate-conductance-Ca2+-activated K+ channels are overexpressed in endometrial cancer and involved in regulating proliferation of endometrial cancer cells].
Wang ZH; Feng YJ; Su M; Yi XF
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):111-5. PubMed ID: 17442186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
